Disposition of 162500 shares by Van Voorhees Seth of NRX Pharmaceuticals at 0.514 subject to Rule 16b-3

NRXP Stock  USD 1.50  0.02  1.32%   
Slightly above 61% of NRX Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding NRX Pharmaceuticals suggests that many traders are alarmed. NRX Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in NRX Pharmaceuticals. Many technical investors use NRX Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by NRX Pharmaceuticals Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 162500 employee stock option plan (right to buy) at 0.514 of NRX Pharmaceuticals by Van Voorhees Seth on 16th of May 2024. This event was filed by NRX Pharmaceuticals with SEC on 2024-06-13. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

NRX Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the NRX Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

NRX Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards NRX Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

NRX Pharmaceuticals Fundamental Analysis

We analyze NRX Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NRX Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NRX Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

NRX Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

NRX Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NRX Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of NRX Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

NRX Pharmaceuticals Related Equities

CINGCingulate   16.10   
0%
92.0%
RNXTRenovoRx   8.70   
0%
50.0%
LGVNLongeveron LLC   3.12   
0%
17.0%
LEXXLexaria Bioscience   0.90   
0%
5.0%
SNTISenti Biosciences   0.76   
0%
4.0%
NTRBNutriband   2.45   
14.0%
0%
VRAXVirax Biolabs   7.41   
42.0%
0%
PHGEBiomx   11.29   
64.0%
0%
QNRXQuoin Pharmaceuticals   12.31   
70.0%
0%
ADTXAditxt   17.39   
100.0%
0%

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.